Tadalafil Maxigra is a medication intended for adult men with erectile dysfunction. This is a condition where a man cannot achieve or maintain an erection sufficient for sexual intercourse. It has been shown that Tadalafil Maxigra significantly improves the ability to achieve an erection sufficient for sexual intercourse.
Tadalafil Maxigra contains the active substance tadalafil, which belongs to a group of medications called phosphodiesterase type 5 inhibitors. After sexual stimulation, Tadalafil Maxigra helps to widen the blood vessels of the penis, allowing blood to flow into the penis. As a result, there is an improvement in erection. Tadalafil Maxigra does not help patients who do not have erectile dysfunction.
It is important to note that Tadalafil Maxigra does not work in the absence of sexual stimulation.
It is also important to arrange foreplay, just like when the patient is not taking medications for erectile dysfunction.
Tadalafil Maxigra is not intended for use in women.
If there is no improvement after taking the medication or the patient feels worse, they should contact their doctor.
Before starting to take Tadalafil Maxigra, the patient should use the questionnaire attached to the packaging. In case of any doubts, the doctor or pharmacist should be consulted.
It should be remembered that sexual activity is associated with a certain risk in patients with heart disease, as it puts an additional strain on the heart. If there are heart problems (including those resulting from the questionnaire that Tadalafil Maxigra should not be used due to heart problems), the doctor or pharmacist should be informed.
The patient should inform their doctor before taking the medication if they have any of the following conditions:
It is not known whether Tadalafil Maxigra is effective in patients:
If during the use of Tadalafil Maxigra there is a sudden worsening of vision or sudden loss of vision, or the image is distorted, blurred, the use of Tadalafil Maxigra should be stopped and the doctor should be consulted immediately.
In some patients taking tadalafil, a worsening or sudden loss of hearing has been observed.
Although it is not known whether this event is directly related to the use of tadalafil, if there is a worsening or sudden loss of hearing, the use of Tadalafil Maxigra should be stopped and the doctor should be consulted immediately.
Tadalafil Maxigra should not be used concurrently with other oral or topical medications used to treat erectile dysfunction.
Tadalafil Maxigra should not be used concurrently with therapies for pulmonary arterial hypertension (PAH) using sildenafil or other PDE5 inhibitors.
Other medications for erectile dysfunction, e.g., containing sildenafil (including Maxigra Go, Maxigra Max, Sildenafil PPH, Viagra), should not be taken within 48 hours of taking Tadalafil Maxigra.
Tadalafil Maxigra should not be taken if erectile dysfunction has not been diagnosed.
Consuming alcohol may affect the patient's ability to achieve an erection and may cause a transient decrease in blood pressure. If the patient has taken Tadalafil Maxigra or plans to take it, they should not consume large amounts of alcohol (blood alcohol concentration 0.08% or higher), as this may increase the risk of dizziness when standing up.
The doctor should be consulted if, after taking Tadalafil Maxigra, there is no erection or the duration of the erection is not sufficient for sexual intercourse.
lie down or sit and wait for the symptoms to pass,
Tadalafil Maxigra is not intended for use in children and adolescents under the age of 18.
Before taking Tadalafil Maxigra, the patient should use the questionnaire attached to the packaging. In case of any doubts, the doctor or pharmacist should be consulted.
The medications listed below may be available under different trade names. Therefore, it is necessary to carefully check the packaging and patient leaflet of the medication being taken to determine the active substance of the medication.
Tadalafil Maxigra may interact with some medications, especially those used to treat angina pectoris. If the patient's condition worsens and requires immediate medical attention, they should inform their doctor about taking Tadalafil Maxigra and the time of its administration. This is very important due to the long duration of action of this medication. Tadalafil Maxigra should not be taken concurrently with other medications without the doctor's recommendation.
It is not recommendedto take Tadalafil Maxigra if the patient is taking medications from the nitrate group, as their concurrent use may lead to dangerous lowering of blood pressure.
The group of nitrates includes the following medications:
Tadalafil Maxigra should not be taken if the patient is taking medications or agents that release nitric oxide (such as amyl nitrite, so-called "poppers"), as their concurrent use may lead to dangerous lowering of blood pressure.
Tadalafil Maxigra may affect the action of some medications or other medications may affect the action of Tadalafil Maxigra. Before taking Tadalafil Maxigra, the patient should consult their doctor or pharmacist if they are taking:
Information on the effect of alcohol is provided in section 3. Grapefruit juice may affect the efficacy of Tadalafil Maxigra, and therefore, it should be consumed with caution.
Tadalafil Maxigra is not intended for use in women.
Fertility
When administered to dogs, a decrease in sperm production in the testes was observed. A decrease in sperm concentration was observed in some men. It is unlikely to lead to infertility.
In some men taking tadalafil during clinical trials, dizziness was reported, so it is necessary to know one's reaction to the tablets before making a decision to drive or operate machinery.
If the patient has previously been diagnosed with intolerance to some sugars, they should consult their doctor before taking the medication.
The medication contains less than 1 mmol (23 mg) of sodium per coated tablet, which means the medication is considered "sodium-free".
This medication should always be taken exactly as described in this patient leaflet or according to the doctor's or pharmacist's recommendations. In case of any doubts, the doctor or pharmacist should be consulted.
Tadalafil Maxigra tablets are intended for oral use only in men.
The tablets should be swallowed whole, with a small amount of water. The tablets can be taken regardless of meals.
The medication should be taken at least 30 minutes before planned sexual activity. The medication may be effective for up to 36 hours after taking the tablet.
The medication is for occasional use, as needed.
It is important to note that Tadalafil Maxigra does not work in the absence of sexual stimulation.
It is also important to arrange foreplay, just like when the patient is not taking medications for erectile dysfunction.
Tadalafil Maxigra should not be used concurrently with other oral or topical medications used to treat erectile dysfunction.
Tadalafil Maxigra should not be used concurrently with therapies for pulmonary arterial hypertension (PAH) using sildenafil or other PDE5 inhibitors.
Other medications for erectile dysfunction, e.g., containing sildenafil (including Maxigra Go, Maxigra Max, Sildenafil PPH, Viagra), should not be taken within 48 hours of taking Tadalafil Maxigra.
Tadalafil Maxigra should not be taken if erectile dysfunction has not been diagnosed.
Consuming alcohol may affect the patient's ability to achieve an erection and may cause a transient decrease in blood pressure. If the patient has taken Tadalafil Maxigra or plans to take it, they should not consume large amounts of alcohol (blood alcohol concentration 0.08% or higher), as this may increase the risk of dizziness when standing up.
The doctor should be consulted if, after taking Tadalafil Maxigra, there is no erection or the duration of the erection is not sufficient for sexual intercourse.
The doctor should be informed about this. Side effects described in section 4 may occur.
A double dose should not be taken to make up for a missed tablet. Tadalafil Maxigra should not be taken more than once a week.
In case of any further doubts about the use of this medication, the doctor or pharmacist should be consulted.
Like all medications, this medication can cause side effects, although not everyone will experience them. These effects are usually mild or moderate.
Common(observed in less than 1 in 10 patients)
Uncommon(observed in less than 1 in 100 patients)
Rare(observed in less than 1 in 1,000 patients)
Heart attack and stroke have been rarely reported in men taking tadalafil. Most of them had heart problems before starting to take tadalafil.
There have been reports of rare cases of partial, transient, or permanent vision loss or blindness in one or both eyes.
In men taking tadalafil, several additional rare side effectshave been reported, which were not observed during clinical trials. These include:
Dizziness was reported more frequently in men over 75 years old taking tadalafil. Diarrhea was reported more frequently in men over 65 years old taking tadalafil.
If any side effects occur, including any side effects not listed in this leaflet, the doctor or pharmacist should be informed. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects can help gather more information on the safety of the medication.
There are no special recommendations for storing the medication.
The medication should be stored out of sight and reach of children.
The medication should not be used after the expiration date stated on the packaging and blister.
The expiration date refers to the last day of the specified month.
Medications should not be disposed of in sewage or household waste containers. The pharmacist should be asked how to dispose of unused medications. This will help protect the environment.
Light orange, elongated, biconvex, coated tablets with a dividing line on one side; length 10.9-11.4 mm, width 5.4-5.9 mm. The dividing line on the tablet is not intended for breaking the tablet.
The medication is available in PVC/PVDC/Aluminum blisters in a cardboard box containing 2 or 4 coated tablets.
Zakłady Farmaceutyczne POLPHARMA S.A.
ul. Pelplińska 19, 83-200 Starogard Gdański
phone: +48 22 364 61 01
Zakłady Farmaceutyczne POLPHARMA S.A.
ul. Pelplińska 19, 83-200 Starogard Gdański
Pharmacare Premium Ltd,
HHF003 Hal Far Industrial Estate,
Birzebbugia, BBG3000, Malta
Zakłady Farmaceutyczne POLPHARMA S.A.
Production Plant in Nowa Dęba
ul. Metalowca 2, 39-460 Nowa Dęba
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.